These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17054379)
1. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study. Aller P; Garnier N; Genest M J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379 [TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer. Aller P; Voiry L; Garnier N; Genest M Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449 [TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer. Garnier N; Crouzy S; Genest M J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604 [TBL] [Abstract][Full Text] [Related]
4. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations. Sajot N; Genest M J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846 [TBL] [Abstract][Full Text] [Related]
5. Transmembrane peptides from tyrosine kinase receptor. Mutation-related behavior in a lipid bilayer investigated by molecular dynamics simulations. Samna Soumana O; Aller P; Garnier N; Genest M J Biomol Struct Dyn; 2005 Aug; 23(1):91-100. PubMed ID: 15918680 [TBL] [Abstract][Full Text] [Related]
6. Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains. Beevers AJ; Kukol A J Mol Graph Model; 2006 Oct; 25(2):226-33. PubMed ID: 16434222 [TBL] [Abstract][Full Text] [Related]
7. Structure prediction of the dimeric neu/ErbB-2 transmembrane domain from multi-nanosecond molecular dynamics simulations. Sajot N; Genest M Eur Biophys J; 2000; 28(8):648-62. PubMed ID: 10663532 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form. Garnier N; Genest D; Duneau JP; Genest M Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995 [TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the dimerization of transmembrane alpha-helices. Psachoulia E; Marshall DP; Sansom MS Acc Chem Res; 2010 Mar; 43(3):388-96. PubMed ID: 20017540 [TBL] [Abstract][Full Text] [Related]
11. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394 [TBL] [Abstract][Full Text] [Related]
12. The transmembrane domain of the oncogenic mutant ErbB-2 receptor: a structure obtained from site-specific infrared dichroism and molecular dynamics. Beevers AJ; Kukol A J Mol Biol; 2006 Sep; 361(5):945-53. PubMed ID: 16889796 [TBL] [Abstract][Full Text] [Related]
13. Specificity of helix packing in transmembrane dimer of the cell death factor BNIP3: a molecular modeling study. Vereshaga YA; Volynsky PE; Pustovalova JE; Nolde DE; Arseniev AS; Efremov RG Proteins; 2007 Nov; 69(2):309-25. PubMed ID: 17600828 [TBL] [Abstract][Full Text] [Related]
14. Structural and thermodynamic insight into the process of "weak" dimerization of the ErbB4 transmembrane domain by solution NMR. Bocharov EV; Mineev KS; Goncharuk MV; Arseniev AS Biochim Biophys Acta; 2012 Sep; 1818(9):2158-70. PubMed ID: 22579757 [TBL] [Abstract][Full Text] [Related]
15. Helix-helix interactions in membrane proteins: coarse-grained simulations of glycophorin a helix dimerization. Psachoulia E; Fowler PW; Bond PJ; Sansom MS Biochemistry; 2008 Oct; 47(40):10503-12. PubMed ID: 18783247 [TBL] [Abstract][Full Text] [Related]
16. Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers. Sharpe S; Barber KR; Grant CW Biochemistry; 2000 May; 39(21):6572-80. PubMed ID: 10828974 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a membrane protein folding motif, the Ser zipper, using designed peptides. North B; Cristian L; Fu Stowell X; Lear JD; Saven JG; Degrado WF J Mol Biol; 2006 Jun; 359(4):930-9. PubMed ID: 16697010 [TBL] [Abstract][Full Text] [Related]
18. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant. Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588 [TBL] [Abstract][Full Text] [Related]
19. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Smith SO; Smith C; Shekar S; Peersen O; Ziliox M; Aimoto S Biochemistry; 2002 Jul; 41(30):9321-32. PubMed ID: 12135353 [TBL] [Abstract][Full Text] [Related]
20. Role of hydrogen bonding and helix-lipid interactions in transmembrane helix association. Lee J; Im W J Am Chem Soc; 2008 May; 130(20):6456-62. PubMed ID: 18422318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]